VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 14 filers reported holding VIRPAX PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,976 | -15.2% | 6,220 | +14.5% | 0.00% | – |
| Q2 2023 | $5,868 | +146600.0% | 5,433 | -0.5% | 0.00% | – |
| Q1 2023 | $4 | +33.3% | 5,463 | +6.5% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 5,130 | +14.4% | 0.00% | – |
| Q3 2022 | $5,000 | +25.0% | 4,486 | +72.4% | 0.00% | – |
| Q2 2022 | $4,000 | +100.0% | 2,602 | +304.7% | 0.00% | – |
| Q4 2021 | $2,000 | – | 643 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 292,790 | $234,203 | 0.17% |
| OSAIC HOLDINGS, INC. | 600 | $479 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 100,875 | $80,700 | 0.00% |
| WELLS FARGO & COMPANY/MN | 63 | $50 | 0.00% |
| NORTHERN TRUST CORP | 15,221 | $12,175 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 63,928 | $51,170 | 0.00% |
| MORGAN STANLEY | 150 | $120 | 0.00% |
| BlackRock Inc. | 464 | $371 | 0.00% |
| Tower Research Capital LLC (TRC) | 6,220 | $4,976 | 0.00% |